Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Hikma Pharmaceuticals PLC (HIKl)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,789.00 +1.00    +0.06%
- Closed. Currency in GBP ( Disclaimer )
  • Volume: 72,496
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1,769.00 - 1,801.00
Type:  Equity
Market:  Euro Zone
ISIN:  GB00B0LCW083 
Hikma Pharma 1,789.00 +1.00 +0.06%

HIKl Share Price Overview

 
Assess today's live Hikma Pharmaceuticals PLC (HIK) share price, performance and insights using our live London: HIK stock exchange data.

Analyse the historical data and Hikma Pharmaceuticals PLC share price performance charts on this page. Our technical summary section provides analysis on Hikma Pharma share price buy/sell indicators using real-time data (or discuss the Hikma Pharma (HIK) stock price today with other investors in the Hikma Pharma LON share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current LON HIK share price (ISIN: GB00B0LCW083) to enhance your trading decisions with our free investment tools and resources.

What Is the Hikma Pharmaceuticals PLC Share Price Today?
The Hikma Pharma share price today is 1,789.00.

What Is the Stock Symbol for Hikma Pharmaceuticals PLC
The stock symbol (or 'ticker') for Hikma Pharmaceuticals is "HIK."

What Stock Exchange Does Hikma Pharmaceuticals PLC Trade On?
Hikma Pharmaceuticals is listed and trades on the London stock exchange.

Is Hikma Pharmaceuticals PLC a Good Stock to Buy?
Determining whether Hikma Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close1,788
Day's Range1,769 - 1,801
Revenue2.88B
Open1,784
52 wk Range1,710.25 - 2,221
EPS0.86
Volume72,496
Market Cap3.97B
Dividend (Yield)0.72 (3.21%)
Average Volume (3m)47,947
P/E Ratio26.02
Beta0.446
1-Year Change - 0.86%
Shares Outstanding221,885,259
Next Earnings DateN/A
What is your sentiment on Hikma Pharma?
or
Market is currently closed. Voting is open during market hours.

Hikma Pharmaceuticals PLC News Today


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Neutral Buy Neutral Strong Sell Sell
Technical Indicators Sell Strong Buy Strong Buy Strong Sell Strong Sell
Summary Neutral Strong Buy Buy Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish doji Star 1W Current
Completed Patterns
Three Inside Up 1M 3 Jan 24
Bullish Engulfing 1W 4 Mar 17, 2024
Bullish doji Star 1W 5 Mar 10, 2024

Hikma Pharmaceuticals PLC Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  London 1,789.00 1,750.00 2,222.00 968,551 +0.85% GBP  
  BATS Europe 1,789.00 0.00 0.00 72,496 +0.06% GBP  
  OTC Markets 46.5 0.0 0.0 247 0.00% USD  
  Frankfurt 20.600 21.000 21.200 0 -0.96% EUR  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 169.80 187.90 163.55 +9.10 +5.66% 35.30M  
  Rolls-Royce Holdings 402.50 406.71 398.30 +1.10 +0.27% 34.65M  
  EasyJet 530.00 547.00 526.40 +11.80 +2.28% 15.43M  
  Lloyds Banking 51.00 51.30 50.62 +0.58 +1.15% 95.48M 18/04  
  BP 512.40 515.10 508.20 -4.40 -0.85% 36.63M 18/04  
  Ocado 350.00 350.50 3.48 +1.80 +0.52% 3.54M  
  Centamin 128.10 129.50 120.10 -1.60 -1.23% 10.66M  
  Barclays 183.98 183.98 181.14 +4.04 +2.25% 72.90M 18/04  
  HSBC 644.60 645.60 637.60 +8.50 +1.34% 44.84M 18/04  
  BAE Systems 1,287.00 1,316.50 1,272.50 -33.00 -2.50% 11.50M 18/04  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

9100

Equity Type

ORD

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HIK Price Commentary

Write your thoughts about Hikma Pharmaceuticals
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ahmed Yusuf
Ahmed Yusuf Apr 15, 2024 10:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
are there hikma distributors in iraq?
Md Salauddin
Md Salauddin Oct 20, 2022 18:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am working
Md Salauddin
Md Salauddin Oct 20, 2022 18:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Adeel Khan
Adeel Khan Oct 09, 2020 16:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Touch 27 today
Adeel Khan
Adeel Khan Sep 12, 2020 14:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next results will be super. Wait for it to hit £32 before end of this year
Jonny Tr
Jonny Tr Jun 17, 2020 15:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Aim listed Dark Matter Ltd, has more potential
Adeel Khan
Adeel Khan May 11, 2020 17:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This will go up & up
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not as stated here (March 11)
Steve Oliphant
Steve Oliphant Dec 04, 2019 9:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hikma will announce their results for the year ended 31 December 2019 on 27 February 2020
Geoff Laidlaw
Geoff Laidlaw Jun 27, 2018 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any hint of progress on Advair will send this stock much higher still !
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email